Cite
Cooper ZA, Frederick DT, Juneja VR, et al. BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology. 2013;2(10):e26615doi: 10.4161/onci.26615.
Cooper, Z. A., Frederick, D. T., Juneja, V. R., Sullivan, R. J., Lawrence, D. P., Piris, A., Sharpe, A. H., Fisher, D. E., Flaherty, K. T., & Wargo, J. A. (2013). BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology, 2(10), e26615. https://doi.org/10.4161/onci.26615
Cooper, Zachary A, et al. "BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes." Oncoimmunology vol. 2,10 (2013): e26615. doi: https://doi.org/10.4161/onci.26615
Cooper ZA, Frederick DT, Juneja VR, Sullivan RJ, Lawrence DP, Piris A, Sharpe AH, Fisher DE, Flaherty KT, Wargo JA. BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes. Oncoimmunology. 2013 Oct 01;2(10):e26615. doi: 10.4161/onci.26615. Epub 2013 Oct 15. PMID: 24251082; PMCID: PMC3827093.
Copy
Download .nbib